TRAVIS KYLE: Open Payments
NPI 1003584608 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 26 payments from 15 companies in 2025. Trend: 2023 $271 · 2024 $602 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $53 |
| Novo Nordisk Inc | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| Lilly USA, LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Dexcom, Inc. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
Products named: VOQUEZNA, CAPLYTA, VRAYLAR, Veozah, Wegovy, MOUNJARO, Dexcom G6 Transmitter, SHINGRIX.
Industry payments across TX — which companies pay providers there.
